Potential genetic modifiers of the cystic fibrosis intestinal inflammatory phenotype on mouse chromosomes 1, 9, and 10

BMC Genetics

Volumn 6, Issue , 2005, Pages

  Norkina, Oxana ^a   De Lisle, Robert C ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 9; CONGENIC STRAIN; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA MODIFICATION; ENTERITIS; FEMALE; GENETIC POLYMORPHISM; GENOME; INTESTINE CRYPT; INTESTINE OBSTRUCTION; MALE; MARKER GENE; MECONIUM ILEUS; MOUSE; MOUSE STRAIN; MUCUS; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; WEIGHT GAIN; WILD TYPE;

ANIMALIA;

EID: 25444514022     PISSN: 14712156     EISSN: 14712156     Source Type: Journal    
DOI: 10.1186/1471-2156-6-29     Document Type: Article

References (52)

1. Riordan JR, Rommens JM, Kerem B-S, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou J-L, Drumm ML, Iannuzzi MC, Collins FS, Tsui L-C: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245:1066-1073.
2. Choi JY, Muallem D, Kiselyov K, Lee MG, Thomas PJ, Muallem S: Aberrant CFTR-dependent HCO3- transport in mutations associated with cystic fibrosis. Nature 2001, 410:94-97.
3. - secretion across murine duodenum. Am J Physiol Gastrointest Liver Physiol 1998, 274:G718-G726.
4. Davies JC: Modifier genes in cystic fibrosis. Pediatr Pulmonol 2004, Suppl 26:86-87.
5. Merlo CA, Boyle MP: Modifier genes in cystic fibrosis lung disease. J Lab Clin Med 2003, 141:237-241.
6. Accurso FJ, Sontag MK: Seeking modifier genes in cystic fibrosis. Am J Respir Crit Care Med 2003, 167:289-290.
7. Rowntree RK, Harris A: The phenotypic consequences of CFTR mutations. Ann Hum Genet 2003, 67:471-485.
8. Salvatore F, Scudiero O, Castaldo G: Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes. Am J Med Genet 2002, 111:88-95.
9. Dray X, Kanaan R, Bienvenu T, Desmazes-Dufeu N, Dusser D, Marteau P, Hubert D: Malnutrition in adults with cystic fibrosis. Eur J Clin Nutr 2004,
10. Proesmans M, De Boeck K: Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes. Eur J Pediatr 2003, 162:760-763.
11. Mascarenhas MR: Treatment of Gastrointestinal Problems in Cystic Fibrosis. Curr Treat Options Gastroenterol 2003, 6:427-441.
12. Jeffery P, Zhu J: Mucin-producing elements and inflammatory cells. Novartis Found Symp 2002, 248:51-68.
13. Dray X, Bienvenu T, Desmazes-Dufeu N, Dusser D, Marteau P, Hubert D: Distal intestinal obstruction syndrome in adults with cystic fibrosis. Clin Gastroenterol Hepatol 2004, 2:498-503.
14. Smyth RL, Croft NM, O'Hea U, Marshall TG, Ferguson A: Intestinal inflammation in cystic fibrosis. Arch Dis Child 2000, 82:394-399.
15. Raia V, Maiuri L, De Ritis G, De Vizia B, Vacca L, Conte R, Auricchio S, Londei M: Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients. Pediatr Res 2000, 47:344-350.
16. Rozmahel R, Wilschanski M, Matin A, Plyte S, Oliver M, Auerbach W, Moore A, Forstner J, Durie P, Nadeau J, Bear C, Tsui LC: Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nature Genet 1996, 12:280-287.
17. Gyömörey K, Rozmahel R, Bear CE: Amelioration of intestinal disease severity in cystic fibrosis mice is associated with improved chloride secretory capacity. Pediatr Res 2000, 48:731-734.
18. Zielenski J, Corey M, Rozmahel R, Markiewicz D, Aznarez I, Casals T, Larriba S, Mercier B, Cutting GR, Krebsova A, Macek M, Jr., Langfelder-Schwind E, Marshall BC, DeCelie-Germana J, Claustres M, Palacio A, Bal J, Nowakowska A, Ferec C, Estivill X, Durie P, Tsui LC: Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nat Genet 1999, 22:128-129.
19. Haston CK, McKerlie C, Newbigging S, Corey M, Rozmahel R, Tsui LC: Detection of modifier loci influencing the lung phenotype of cystic fibrosis knockout mice. Mamm Genome 2002, 13:605-613.
20. Kaur S, Norkina O, Ziemer D, Samuelson LC, De Lisle RC: Acidic duodenal pH alters gene expression in the cystic fibrosis mouse pancreas. Am J Physiol Gastrointest Liver Physiol 2004, 286:G480-G490.
21. Norkina O, Kaur S, Ziemer D, De Lisle RC: Inflammation of the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 2004, 286:G1032-G1041.
22. Pemberton AD, Brown JK, Wright SH, Knight PA, McPhee ML, McEuen AR, Forse PA, Miller HR: Purification and characterization of mouse mast cell proteinase-2 and the differential expression and release of mouse mast cell proteinase-1 and -2 in vivo. Clin Exp Allergy 2003, 33:1005-1012.
23. O'Donnell LC, Druhan LJ, Avalos BR: Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation. J Leukoc Biol 2002, 72:478-485.
24. Saito K, Tanaka T, Kanda H, Ebisuno Y, Izawa D, Kawamoto S, Okubo K, Miyasaka M: Gene expression profiling of mucosal addressin cell adhesion molecule- 1+ high endothelial venule cells (HEV) and identification of a leucine- rich HEV glycoprotein as a HEV marker. J Immunol 2002, 168:1050-1059.
25. Bistrup A, Tsay D, Shenoy P, Singer MS, Bangia N, Luther SA, Cyster JG, Ruddle NH, Rosen SD: Detection of a sulfotransferase (HEC-GlcNAc6ST) in high endothelial venules of lymph nodes and in high endothelial venule-like vessels within ectopic lymphoid aggregates: relationship to the MECA-79 epitope. Am J Pathol 2004, 164:1635-1644.
26. Kobayashi M, Mitoma J, Nakamura N, Katsuyama T, Nakayama J, Fukuda M: Induction of peripheral lymph node addressin in human gastric mucosa infected by Helicobacter pylori. Proc Natl Acad Sci U S A 2004, 101:17807-17812.
27. Xue H, O'Neill D, Morrow J, Bank A: A novel mouse gene, HemT, encoding an hematopoietic cell-specific transcript. Gene 1999, 231:49-58.
28. Urieli-Shoval S, Linke RP, Matzner Y: Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol 2000, 7:64-69.
29. Suzuki A, Hanada T, Mitsuyama K, Yoshida T, Kamizono S, Hoshino T, Kubo M, Yamashita A, Okabe M, Takeda K, Akira S, Matsumoto S, Toyonaga A, Sata M, Yoshimura A: CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med 2001, 193:471-481.
30. Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, von Deimling A, Poustka A: DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nature Genet 1997, 17:32-39.
31. Sun FS, Kaur S, Ziemer D, Banerjee S, Samuelson LC, De Lisle RC: Decreased gastric bacterial killing and upregulation of protective genes in the small intestine in the gastrin deficient mouse. Dig Dis Sci 2003, 48:976-985.
32. Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O, Koller BH: An animal model for cystic fibrosis made by gene targeting. Science 1992, 257:1083-1088.
33. Parmley RR, Gendler SJ: Cystic fibrosis mice lacking muc1 have reduced amounts of intestinal mucus. J Clin Invest 1998, 102:1798-1806.
34. Grubb BR, Gabriel SE: Intestinal physiology and pathology in gene-targeted mouse models of cystic fibrosis. Am J Physiol Gastrointest Liver Physiol 1997, 273:G258-G266.
35. Clarke LL, Gawenis LR, Franklin CL, Harline MC: Increased survival of CFTR knockout mice with an oral osmotic laxative. Lab Anim Sci 1996, 46:612-618.
36. Kelley KA, Stamm S, Kozak CA: Expression and chromosome localization of the murine cystic fibrosis transmembrane conductance regulator. Genomics 1992, 13:381-388.
37. Obermeier F, Schwarz H, Dunger N, Strauch UG, Grunwald N, Scholmerich J, Falk W: OX40/OX40L interaction induces the expression of CXCR5 and contributes to chronic colitis induced by dextran sulfate sodium in mice. Eur J Immunol 2003, 33:3265-3274.
38. Ji HB, Liao G, Faubion WA, Abadia-Molina AC, Cozzo C, Laroux FS, Caton A, Terhorst C: Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J Immunol 2004, 172:5823-5827.
39. Smith ML, Olson TS, Ley K: CXCR2- and E-selectin-induced neutrophil arrest during inflammation in vivo. J Exp Med 2004, 200:935-939.
40. Fraser CC, Howie D, Morra M, Qiu Y, Murphy C, Shen Q, Gutierrez-Ramos JC, Coyle A, Kingsbury GA, Terhorst C: Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family. Immunogenetics 2002, 53:843-850.
41. Rumsaeng V, Vliagoftis H, Oh CK, Metcalfe DD: Lymphotactin gene expression in mast cells following Fc(epsilon) receptor I aggregation: modulation by TGF-beta, IL-4, dexamethasone, and cyclosporin A. J Immunol 1997, 158:1353-1360.
42. Li CK, Pender SL, Pickard KM, Chance V, Holloway JA, Huett A, Goncalves NS, Mudgett JS, Dougan G, Frankel G, MacDonald TT: Impaired immunity to intestinal bacterial infection in stromelysin-1 (matrix metalloproteinase-3)-deficient mice. J Immunol 2004, 173:5171-5179.
43. Ayabe T, Satchell DP, Pesendorfer P, Tanabe H, Wilson CL, Hagen SJ, Ouellette AJ: Activation of Paneth cell alpha-defensins in mouse small intestine. J Biol Chem 2002, 277:5219-5228.
44. McCafferty DM, Smith CW, Granger DN, Kubes P: Intestinal inflammation in adhesion molecule-deficient mice: an assessment of P-selectin alone and in combination with ICAM-1 or E-selectin. J Leukoc Biol 1999, 66:67-74.
45. Galli SJ, Tsai M, Gordon JR, Geissler EN, Wershil BK: Analyzing mast cell development and function using mice carrying mutations at W/c-kit or Sl/MGF (SCF) loci. Ann N Y Acad Sci 1992, 664:69-88.:69-88.
46. Puel A, Mevel JC, Bouthillier Y, Feingold N, Fridman WH, Mouton D: Toward genetic dissection of high and low antibody responsiveness in Biozzi mice. Proc Natl Acad Sci U S A 1996, 93:14742-14746.
47. Ouellette AJ: Paneth cells and innate immunity in the crypt microenvironment. Gastroenterology 1997, 113:1779-1784.
48. Zheng S, Xu W, Bose S, Banerjee AK, Haque SJ, Erzurum SC: Impaired nitric oxide synthase-2 signaling pathway in cystic fibrosis airway epithelium. Am J Physiol Lung Cell Mol Physiol 2004, 287:L374-L381.
49. Dumoutier L, Louahed J, Renauld JC: Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 2000, 164:1814-1819.
50. Pfitzner E, Kliem S, Baus D, Litterst CM: The role of STATs in inflammation and inflammatory diseases. Curr Pharm Des 2004, 10:2839-2850.
51. Friis-Hansen L, Sundler F, Li Y, Gillespie PJ, Saunders TL, Greenson JK, Owyang C, Rehfeld JF, Samuelson LC: Impaired gastric acid secretion in gastrin-deficient mice. Am J Physiol Gastrointest Liver Physiol 1998, 274: G561-G568.
52. Eckman EA, Cotton CU, Kube DM, Davis PB: Dietary changes improve survival of CFTR S489X homozygous mutant mouse. Am J Physiol Lung Cell Mol Physiol 1995, 269:L625-L630.